Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke | Zendy

Lan Gao | Zendy; Marj Moodie | Zendy; Peter Mitchell | Zendy; Leonid Churilov | Zendy; Timothy Kleinig | Zendy; Nawaf Yassi | Zendy; Bernard Yan | Zendy; Mark Parsons | Zendy; Geoffrey A. Donnan | Zendy; Stephen M. Davis | Zendy; Bruce Campbell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke

Author(s) -

Lan Gao,

Marj Moodie,

Peter Mitchell,

Leonid Churilov,

Timothy Kleinig,

Nawaf Yassi,

Bernard Yan,

Mark Parsons,

Geoffrey A. Donnan,

Stephen M. Davis,

Bruce Campbell

Publication year - 2020

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.120.029666

Subject(s) - tenecteplase , medicine , modified rankin scale , stroke (engine) , randomized controlled trial , quality adjusted life year , emergency medicine , cost effectiveness , quality of life (healthcare) , fibrinolytic agent , health utilities index , thrombolysis , surgery , tissue plasminogen activator , ischemic stroke , ischemia , myocardial infarction , health related quality of life , mechanical engineering , risk analysis (engineering) , nursing , engineering , disease

Tenecteplase improved functional outcomes and reduced the requirement for endovascular thrombectomy in ischemic stroke patients with large vessel occlusion in the EXTEND-IA TNK randomized trial. We assessed the cost-effectiveness of tenecteplase versus alteplase in this trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research